Skip to main content

and
  1. Article

    Open Access

    Dynamics and durability of HIV-1 neutralization are determined by viral replication

    Human immunodeficiency virus type 1 (HIV-1)-neutralizing antibodies (nAbs) that prevent infection are the main goal of HIV vaccine discovery. But as no nAb-eliciting vaccines are yet available, only data from ...

    Philipp Schommers, Dae Sung Kim, Maike Schlotz, Christoph Kreer in Nature Medicine (2023)

  2. Article

    Open Access

    Tecovirimat for the treatment of severe Mpox in Germany

    In May 2022, a multi-national mpox outbreak was reported in several non-endemic countries. The only licensed treatment for mpox in the European Union is the orally available small molecule tecovirimat, which in O...

    Lennart Hermanussen, Thomas Theo Brehm, Timo Wolf, Christoph Boesecke in Infection (2023)

  3. Article

    Open Access

    Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial

    Patients with cancer are at high risk of severe coronavirus disease 2019 (COVID-19), with high morbidity and mortality. Furthermore, impaired humoral response renders severe acute respiratory syndrome coronavi...

    Claudia M. Denkinger, Maike Janssen, Ulrike Schäkel, Julia Gall in Nature Cancer (2023)

  4. Article

    Open Access

    Powered air-purifying respirators used during the SARS-CoV-2 pandemic significantly reduce speech perception

    Due to the coronavirus disease 2019 (COVID-19) pandemic, interventions in the upper airways are considered high-risk procedures for otolaryngologists and their colleagues. The purpose of this study was to eval...

    Roxanne Weiss, Leon Guchlerner in Journal of Occupational Medicine and Toxic… (2021)

  5. Article

    Open Access

    Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial

    Currently, there are no approved treatments for early disease stages of COVID-19 and few strategies to prevent disease progression after infection with SARS-CoV-2. The objective of this study is to evaluate th...

    Verena Keitel, Björn Jensen, Torsten Feldt, Johannes C. Fischer, Johannes G. Bode in Trials (2021)

  6. Article

    Open Access

    Lung Ultrasound Findings in Patients with COVID-19

    The current SARS-CoV-2 outbreak leads to a growing need of point-of-care thoracic imaging that is compatible with isolation settings and infection prevention precautions. We retrospectively reviewed 17 COVID-1...

    Daniel T. Marggrander, Frauke Borgans, Volkmar Jacobi in SN Comprehensive Clinical Medicine (2020)

  7. Article

    Open Access

    A maltose-regulated large genomic region is activated by the transcriptional regulator MalT in Actinoplanes sp. SE50/110

    Actinoplanes sp. SE50/110 is the industrially relevant producer of acarbose, which is used in the treatment of diabetes mellitus. Recent studies elucidated the expression dynamics in Actinoplanes sp. SE50/110 dur...

    Julian Droste, Martin Kulisch, Timo Wolf in Applied Microbiology and Biotechnology (2020)

  8. No Access

    Article

    Species distribution and clinical features of infection and colonisation with non-tuberculous mycobacteria in a tertiary care centre, central Germany, 2006–2016

    NTM are ubiquitous bacteria that can cause colonisation and infection in immunocompetent and compromised hosts. The aim of this study was to elucidate the epidemiology of infection or colonisation with NTM for...

    Nils Wetzstein, Christian Hügel, Thomas A. Wichelhaus, Michael Hogardt in Infection (2019)

  9. No Access

    Article

    Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV

    Recombinant vesicular stomatitis virus–Zaire Ebola virus (rVSV-ZEBOV) is the most advanced Ebola virus vaccine candidate and is currently being used to combat the outbreak of Ebola virus disease (EVD) in the D...

    Stefanie A. Ehrhardt, Matthias Zehner, Verena Krähling in Nature Medicine (2019)

  10. No Access

    Article

    Preliminary design of advanced flight control system architectures for commercial transport aircraft

    The functional enhancement of flight control systems (FCS) show potential benefits for commercial transport aircraft. Furthermore, the consideration of new technologies and more-electric concepts lead to a sig...

    Thomas Lampl, Timo Wolf, Mirko Hornung in CEAS Aeronautical Journal (2019)

  11. No Access

    Article

    New filovirus disease classification and nomenclature

    The recent large outbreak of Ebola virus disease (EVD) in Western Africa resulted in greatly increased accumulation of human genotypic, phenotypic and clinical data, and improved our understanding of the spect...

    Jens H. Kuhn, Takuya Adachi, Neill K. J. Adhikari in Nature Reviews Microbiology (2019)

  12. Chapter

    Maintenance of Preparedness

    The medical management of patients with highly hazardous communicable diseases (HHCD) will suddenly become important during public health emergencies of international concern but will receive little attention ...

    Timo Wolf in Bioemergency Planning (2018)

  13. Article

    Open Access

    The MalR type regulator AcrC is a transcriptional repressor of acarbose biosynthetic genes in Actinoplanes sp. SE50/110

    Acarbose is used in the treatment of diabetes mellitus type II and is produced by Actinoplanes sp. SE50/110. Although the biosynthesis of acarbose has been intensively studied, profound knowledge about transcript...

    Timo Wolf, Julian Droste, Tetiana Gren, Vera Ortseifen in BMC Genomics (2017)

  14. No Access

    Article

    HIV-1 replication in central nervous system increases over time on only protease inhibitor therapy

    There are concerns about central nervous system (CNS)-replication of HIV-1 in patients on boosted protease inhibitors. Purpose of this study was to compare HIV-1 viral loads (VLs) from patients treated with on...

    Maximilian Donath, Timo Wolf, Martin Stürmer in Medical Microbiology and Immunology (2016)

  15. No Access

    Article

    Rapid regression of Kaposi’s sarcoma of the hard palate under therapy with boosted elvitegravir-containing fixdose antiretroviral combination therapy

    Kaposi’s sarcoma (KS) is a rare vascular tumor that may occur in a severe, rapidly progressive form, namely in HIV/AIDS patients. HIV-associated KS mainly affects the skin and mucous membranes.

    Gundolf Schüttfort, Timo Wolf, Phillip de Leuw, Gerrit Kann, Maximilian Blume in Infection (2016)

  16. No Access

    Article

    Vom Schärfesensor zur mikrobiellen Brennstoffzelle

    Nils Lübke, Timo Wolf, Robert Braun, Christian Rückert, Jörn Kalinowski in BIOspektrum (2014)

  17. Article

    Open Access

    Superimposed high-frequency jet ventilation combined with continuous positive airway pressure/assisted spontaneous breathing improves oxygenation in patients with H1N1-associated ARDS

    Numerous cases of swine-origin 2009 H1N1 influenza A virus (H1N1)-associated acute respiratory distress syndrome (ARDS) bridged by extracorporeal membrane oxygenation (ECMO) therapy have been reported; however...

    Tobias M Bingold, Bertram Scheller, Timo Wolf, Jens Meier in Annals of Intensive Care (2012)

  18. Article

    Open Access

    Growth characterization of CHO DP-12 cell lines with different high passage histories

    Christoph Heinrich, Timo Wolf, Christina Kropp, Stefan Northoff in BMC Proceedings (2011)

  19. Article

    Open Access

    Decreased HIV diversity after allogeneic stem cell transplantation of an HIV-1 infected patient: a case report

    The human immunodeficiency virus type 1 (HIV-1) coreceptor use and viral evolution were analyzed in blood samples from an HIV-1 infected patient undergoing allogeneic stem cell transplantation (SCT). Corecepto...

    Christel Kamp, Timo Wolf, Ignacio G Bravo, Benjamin Kraus in Virology Journal (2010)